C12R 1 - Micro-organisms - Patents Sitemap

Patents for C12R 1 - Micro-organisms (92,025)
12/2001
12/04/2001	CA2062729C Interferon purification process
12/04/2001	CA2053829C Vaccines against equine herpesviruses and the preparation thereof
12/04/2001	CA2027635C Erythropoietin isoforms
12/04/2001	CA1341324C Esterase enzymes used in the process for the preparation of 2-arylpropionic acids
11/2001
11/30/2001	CA2349057A1 Enzymatic oxidations
11/29/2001	WO2001090397A1 Enzymatic conversion of epoxides
11/29/2001	WO2001090395A1 A method for manufacturing highly-concentrated polyglutamic acid with additional supply of saccharides
11/29/2001	WO2001090394A1 Process for producing antioxidant
11/29/2001	WO2001090337A2 Detection of rna
11/29/2001	WO2001090333A2 Recombinant bacterial phytases and uses thereof
11/29/2001	WO2001090317A2 Beta-galactosidase isolated from a bifidobacterium
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090143A2 Polypeptides containing polymorphisms of the repeated regions of pertactin in bordetella pertussis, bordetella parapertussis and bordetella bronchiseptica. their use in diagnostics, and in immunogenic compositions
11/29/2001	WO2001089559A2 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/29/2001	WO2001089297A2 A bioinsecticide formulation consisting of bacillus thuringiensis var israelensis, and its concerning manufacture proceedings
11/29/2001	WO2001044458A3 Bovine immunodeficiency virus (biv) based vectors
11/29/2001	WO2001042445A3 USE OF RECOMBINANT PARAINFLUENZA VIRUSES (PIVs) AS VECTORS TO PROTECT AGAINST INFECTION AND DISEASE CAUSED BY PIV AND OTHER HUMAN PATHOGENS
11/29/2001	WO2001027304A3 Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex dna
11/29/2001	WO2001025433A3 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization
11/29/2001	WO2001025246A3 Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same
11/29/2001	WO2001000846A3 Linoleate isomerase
11/29/2001	US20010047090 VANILREP1 polynucleotides and VANILREP1 polypeptides
11/29/2001	US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors
11/29/2001	US20010046698 Method capable of increasing competency of bacterial cell transformation
11/29/2001	US20010046697 Bacillus natto culture extract
11/29/2001	US20010046692 Derived from Pseudomonas jessenii
11/29/2001	US20010046691 Enhanced production of lipids containing polyenoic fatty acid by very high density cultures of eukaryotic microbes in fermentors
11/29/2001	US20010046484 Adding viable bacillus to feed
11/29/2001	DE10025033A1 Verfahren zur elektrischen Energiegewinnung mit Hilfe einer Brennstoffzelle Method for the electrical energy using a fuel cell
11/29/2001	CA2409874A1 Porcine reproductive and respiratory syndrome virus (prrsv) recombinant avipoxvirus vaccine
11/28/2001	EP1158054A1 Enzymatic conversion of epoxides
11/28/2001	EP1158052A1 Beta-primeverosidase gene
11/28/2001	EP1158051A1 Process for producing astaxanthin
11/28/2001	EP1158048A1 Photoprotein derived from Okinawan squid and gene encoding the photoprotein
11/28/2001	EP1158046A1 Superoxide Dismutase-4
11/28/2001	EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof
11/28/2001	EP1157103A2 Production of helper dependent adenovirus vectors based on use of endonucleases
11/28/2001	EP1157094A2 Method for the purification, recovery, and sporulation of cysts and oocysts
11/28/2001	EP0789588A4 Method for making a medicament for treating secondary immunodeficiency
11/28/2001	EP0783520B1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens
11/28/2001	EP0628075B1 Endo-1,4-beta-d-glucanase
11/28/2001	EP0460190B2 Method for detecting malignant diseases
11/28/2001	CN1324409A Method of producing gamma-decalactone
11/28/2001	CN1324400A Method of screening for large offspring syndrome
11/28/2001	CN1324247A Process and materials for the repid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies
11/28/2001	CN1324211A Manipulation of tocopherol levels in transgenic plants
11/28/2001	CN1075557C Production of ammonium acrylate
11/27/2001	US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
11/27/2001	US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome
11/27/2001	US6323010 Providing substrates which comprise 2-hydroxybutyric acid in biological system which is genetically engineered to express one or more enzymes selected from the group consisting of polyhydroxyalkanoate synthase, acyl-coa transferase, etc.
11/27/2001	US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds
11/27/2001	US6322995 Recombinant gram positive bacterium used for producing riboflavin
11/27/2001	US6322809 Containing one or more bacteria entrapped in liposome
11/27/2001	US6322795 Papilloma viruses, agents for detecting them and for treating diseases caused by such viruses
11/27/2001	CA2241266C Enzyme composition for tissue dissociation
11/27/2001	CA2240392C Multimer forms of interleukin-16 (il-16), process for the preparation and use thereof
11/27/2001	CA2074837C Methods of producing hybrid g protein-coupled receptors
11/27/2001	CA2063511C Method for producing human serum albumin
11/27/2001	CA2021912C Erythropoietin (epo) peptides and antibodies directed against these
11/27/2001	CA2005421C A process for the preparation of l-phosphinothricin
11/22/2001	WO2001088511A1 Grating optical waveguide structure for multi-analyte determinations and the use thereof
11/22/2001	WO2001088121A1 Vector constructs
11/22/2001	WO2001088095A1 Microorganisms for treatment or prevention of obesity and diabetes mellitus, and pharmaceutical composition containing the same
11/22/2001	WO2001088093A1 Complex culture, process for producing complex culture, pre-culture, process for producing pre-culture and process for producing microbial preparations
11/22/2001	WO2001087982A2 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	WO2001087981A2 Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof
11/22/2001	WO2001087884A2 Polyketide derivatives
11/22/2001	WO2001087062A2 Microinjection of cryoprotectants for preservation of cells
11/22/2001	WO2001064848A9 Method and apparatus for culturing cell or tissue
11/22/2001	WO2001023597A9 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus
11/22/2001	US20010044523 Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells
11/22/2001	US20010044522 Polypeptides, antibodies against them and nucleic acids encoding them; detecting activated CD4+ T-cells to diagnose a disease or condition of the immune system; screening for immunosuppressants
11/22/2001	US20010044139 Method for producing L-phenylalanine
11/22/2001	US20010044133 Phage-dependent super-production of biologically active protein and peptides
11/22/2001	US20010044120 Useful for the prevention or treatment of peptic ulcers in humans or mammals.
11/22/2001	US20010044118 Immunoassay for LSD and 2-oxo-3-hydroxy-LSD
11/22/2001	US20010044100 Messenger RNA is used as a target (marker) which exists mainly on float in the cytoplasm and is a transcriptional product of a gene instead of using the translation product.
11/22/2001	US20010043922 Recombinants of the multiply deficient adenoviral vectors; a therapeutic method and their use particularly relating to gene therapy and vaccination
11/22/2001	CA2409746A1 Immunotoxin fusion proteins and means for expression thereof
11/22/2001	CA2409102A1 Microinjection of cryoprotectants for preservation of cells
11/22/2001	CA2407259A1 Polyketide derivatives
11/21/2001	EP1156117A2 Methods for isolating modulators of carotenoid biosynthesis enzymes
11/21/2001	EP1156110A2 G-protein coupled receptor (HFGAN72Y)
11/21/2001	EP1156106A1 Novel enzyme having decoloring activity and method for decoloring dyes by using the same
11/21/2001	EP1155700A2 Lymphocyte chemoattractant factor and uses thereof
11/21/2001	EP1155138A2 Method for preparing optically active 3,3,3-trifluoromethyl-2-alkyl propionic acid derivatives
11/21/2001	EP1155136A2 Helper adenovirus / helper-dependent adenovirus vector system based on site-specific recombinase activity
11/21/2001	EP1155132A1 Production of heterologous polypeptides from freshwater caulobacter
11/21/2001	EP1154979A1 Microbial process for preparing pravastatin
11/21/2001	EP1154797A2 Multi-mutant diphtheria toxin vaccines
11/21/2001	EP1154692A1 A method of controlling fungal pathogens, and agents useful for same
11/21/2001	EP0854727B1 Tumor rejection antigens presented by hla-b44 molecules, and uses thereof
11/21/2001	EP0842191B1 Cyclosporin derivatives with anti-hiv activity
11/21/2001	EP0773962B1 Antibodies which activate an erythropoietin receptor
11/21/2001	EP0722317B1 Liposomes containing particulate materials
11/21/2001	EP0536186B1 Bone and cartilage inductive proteins
11/21/2001	CN1323351A Heteropolysaccharide produced by an agrobacterium radiobacter
11/21/2001	CN1323349A Plastid-targeting nucleic acid sequence, beta-amylase sequence, a stimulus-responsive promoter and uses thereof
11/21/2001	CN1323348A Delivery system for porcine somatotropin
11/21/2001	CN1322768A Polyhydroxy alkanoate and process for producing them with microbe

1 ... 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 ... 921